Gui-rong Liu

157 Baojian Road
Harbin, 150081, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Secoisolariciresinol diglucoside resolves systemic and skin inflammation in psoriatic mice by ameliorating the gut microbiome and modulating immune responses.

Secoisolariciresinol diglucoside resolves systemic and skin inflammation in psoriatic mice by ameliorating the gut microbiome and modulating immune responses.

Journal: Food & function

Published: April 21, 2026

Lignans Alleviate Depression by Modulating the Gut-Brain Axis: Effect and Mechanism Based on Multi-Omics Analyses.

Lignans Alleviate Depression by Modulating the Gut-Brain Axis: Effect and Mechanism Based on Multi-Omics Analyses.

Journal: BioFactors (Oxford, England)

Published: March 27, 2026

Akkermansia muciniphila NND9 Mitigates Ulcerative Colitis by Ameliorating the Gut Barrier via Suppressing DR5 Expression in a Mouse Model.

Akkermansia muciniphila NND9 Mitigates Ulcerative Colitis by Ameliorating the Gut Barrier via Suppressing DR5 Expression in a Mouse Model.

Journal: Microorganisms

Published: March 17, 2026

Streptomyces sp. BI87 from human gut: potent anticancer activities and divergence from known Streptomyces lineages.

Streptomyces sp. BI87 from human gut: potent anticancer activities and divergence from known Streptomyces lineages.

Journal: Microbiology spectrum

Published: August 13, 2025

Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment.

Enterolactone and THBS1-3TSR synergistically inhibit ovarian cancer and suppress angiogenesis in the tumour microenvironment.

Journal: British journal of pharmacology

Published: January 27, 2025

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

The combination of flaxseed lignans and PD-1/ PD-L1 inhibitor inhibits breast cancer growth via modulating gut microbiome and host immunity.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: December 29, 2024

Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.

Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.

Journal: Virology

Published: December 14, 2024

Successful Outcome of a Patient with Concomitant Pancreatic and Renal Carcinoma Receiving Secoisolariciresinol Diglucoside Therapy Alone: A Case Report.

Successful Outcome of a Patient with Concomitant Pancreatic and Renal Carcinoma Receiving Secoisolariciresinol Diglucoside Therapy Alone: A Case Report.

Journal: International medical case reports journal

Published: October 23, 2023

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.

Enterolactone and trabectedin suppress epithelial ovarian cancer synergistically via upregulating THBS1.

Journal: Phytotherapy research : PTR

Published: April 15, 2023

Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses.

Fecal microbiota transplantation inhibits colorectal cancer progression: Reversing intestinal microbial dysbiosis to enhance anti-cancer immune responses.

Journal: Frontiers in microbiology

Published: December 18, 2022

Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types.

Novel Bacillus strains from the human gut exert anticancer effects on a broad range of malignancy types.

Journal: Investigational new drugs

Published: October 04, 2019

E. coli diversity: low in colorectal cancer.

E. coli diversity: low in colorectal cancer.

Journal: BMC medical genomics

Published: April 02, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026